Home / Germany / COSMO Pharmaceuticals N.V.
COSMO Pharmaceuticals N.V.
Short position disclosed on December 5, 2018.
Evolution of the disclosed total
December 5, 2018 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| BlueCrest Capital Management Limited | 0.50% | unchanged | December 5, 2018 |
In the United States CMOPF (OTC): 7,450 shares sold short on August 31, 2026. FINRA names no fund.
On the other side: the funds that hold COSMO Pharmaceuticals N.V. Titelia
Get the moves on COSMO Pharmaceuticals N.V. by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| December 5, 2018 | BlueCrest Capital Management Limited | 0.50% | still open |
Download 1 filing as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Germany
- TUI AG 8.56% of the capital sold short
- HelloFresh SE 7.84% of the capital sold short
- AUTO1 Group SE 7.23% of the capital sold short
- Hugo Boss AG 7.19% of the capital sold short
- Zalando SE 6.11% of the capital sold short
- Gerresheimer AG 5.99% of the capital sold short
- PVA TePla AG 5.72% of the capital sold short
- Velo3D Inc 5.72% of the capital sold short
- Cancom SE 5.55% of the capital sold short
- Puma SE 5.41% of the capital sold short
- RENK Group AG 5.31% of the capital sold short
- TAG Immobilien AG 5.19% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, COSMO Pharmaceuticals N.V., source Bundesanzeiger, data as at December 5, 2018, https://www.quivad.com/action/cosmo-pharmaceuticals-n-v